Blog: Opioid epidemic - The pain persists
A Sunday Times investigation recently revealed Britain is in danger of replicating the painkiller epidemic that has ravaged the US — particularly in the north, where the drugs are prescribed four times more than in London. Dorothy Flower, partner, and Emma Kislingbury, associate at RPC, explore how this might impact pharmaceutical companies, medical practitioners, healthcare providers, and their insurers.
‘Epidemic’, ‘crisis’, ‘timebomb’; these are, unfortunately, all too familiar terms used to describe the impact opioids - a class of drugs that include the illegal drug heroin, synthetic opioids such
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe
You are currently unable to print this content. Please contact info@postonline.co.uk to find out more.
You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@postonline.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@postonline.co.uk